Role of eprinomectin as inhibitor of the ruminant ABCG2 transporter: Effects on plasma distribution of danofloxacin and meloxicam in sheep
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Research in Veterinary Science
- Vol. 136, 478-483
Abstract
No abstract availableKeywords
Funding Information
- Junta de Castilla y Leon Consejeria de Educacion
- State Agency of Research
- Government of Spain Ministry of Education Culture and Sports
This publication has 19 references indexed in Scilit:
- Novelin vitrosystems for prediction of veterinary drug residues in ovine milk and dairy productsFood Additives & Contaminants: Part A, 2014
- Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporterThe Veterinary Journal, 2013
- Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheepThe Veterinary Journal, 2013
- P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistanceInternational Journal for Parasitology: Drugs and Drug Resistance, 2012
- In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheepThe Veterinary Journal, 2012
- ABCG2 transporter: therapeutic and physiologic implications in veterinary speciesJournal of Veterinary Pharmacology and Therapeutics, 2011
- Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectinJournal of Veterinary Pharmacology and Therapeutics, 2010
- Failure of ivermectin and eprinomectin to control Amblyomma parvum in goats: Characterization of acaricidal activity and drug pharmacokinetic dispositionVeterinary Parasitology, 2008
- Modulation of human BCRP (ABCG2) activity by anti-HIV drugsJournal of Antimicrobial Chemotherapy, 2006
- Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of CimetidineThe Journal of Pharmacology and Experimental Therapeutics, 2005